April 21, 2017 | Story Review

NBC’s single source report on device for treating cluster headaches lacks balance

Relying on just one source, the story doesn’t tackle any of the weaknesses of the research, including its failure to reach its goal. Only when a smaller sub-group of volunteers was analyzed did the device show a statistical improvement in symptoms.

2 Star

FDA Approves Vagus Nerve Stimulator to Treat Cluster Headaches

April 20, 2017 | Story Review

CBS’s anecdotal story on botox for major depression omits major conflicts of interest

Relying on just one expert source invites trouble, particularly when the source has multiple ties to the intervention and stands to gain financially from its approval.

2 Star

Botox tested to help treat depression and social anxiety

April 18, 2017 | Story Review

AP story on trans fats ban: Strong on sourcing, but left out key detail about study findings

Although the headline admirably opted for the term “linked,” the story lede translates that into a causal statement.

5 Star

TRANS FATS BAN LINKED WITH FEWER NY HEART ATTACKS & STROKES

April 18, 2017 | Story Review

‘That finding could be due to chance:’ Reuters Health uses caution to explain study on trans fats ban

One weak point for the story was the lack of independent sources.

5 Star

Hospitalizations drop where laws restrict trans fats

April 14, 2017 | Story Review

Lack of independent sources hinders AP story on new drug that treats side effect caused by antipsychotics

More sourcing would have better answered: Is the evidence for the drug as solid as the company is saying it is?

4 Star

1st drug OK'd for movement disorder caused by certain meds

April 13, 2017 | Story Review

Facial-recognition software for diagnosing genetic disorders: STAT leaves too many questions unanswered

It’s also difficult to understand the “market” for this startup if most patients in the U.S. have access to genetic testing, which is needed for an actual diagnosis

2 Star

Facial-recognition software finds a new use: diagnosing genetic disorders

April 10, 2017 | Story Review

Stem cell ‘patch’ for heart failure: HealthDay cautions readers about small study size, lack of control group

The story could have dug a little deeper–heart surgery is not without risks, nor costs–but those points weren’t included.

3 Star

Can Stem Cell 'Patch' Help Heart Failure?

April 10, 2017 | Story Review

Walk or run for exercise? Vox provides informative look at risks and benefits of both

In particular, the story does a great job quantifying the potential risks of running and of comparing the likelihood of injury from running to those for walking.

5 Star

Should you walk or run for exercise? Here's what the science says.

Toolkit

Tips for Understanding Studies

View More

Toolkit